-
Organizational Restructuring at AstraZeneca China Aims to Strengthen Oncology Business
AstraZeneca China implemented a significant organizational restructuring, dismantling and reorganizing its county-level oncology teams, and integratin...
2024-07-08 15:56 -
Medtronic Undergoes Leadership Shakeup Amid Sweeping Transformation
Rob Hoedt, Executive Vice President and President of Medtronic's global regions, revealed that he will be retiring from his distinguished career on Ju...
2024-07-08 15:55 -
AbbVie Announces New CEO Robert A. Michael to Succeed Richard A. Gonzalez
On July 1, 2024, the global pharmaceutical company AbbVie (NYSE: ABBV) officially announced that Mr. Robert A. Michael will take on the role of Chief ...
2024-07-08 15:54 -
Kisunla: A New Breakthrough in Alzheimer's Treatment
Eli Lilly proudly announced that its investigational anti-Aβ antibody Donanemab (brand name Kisunla) has been approved by the U.S. Food and Drug Admi...
2024-07-08 15:50 -
Renowned Leader Departs Merck China: Examining the Legacy of Tang Xiaochun
Noteworthy news has arrived - Tang Xiaochun, the head of Merck China's Vaccine Business Unit and Assistant Vice President, has stepped down from his r...
2024-07-08 15:49 -
Biotech Shakeup: Connect Biopharm Undergoes Major Leadership Transition
On June 12th, Connect Biopharm filed a notable report with the US Securities and Exchange Commission (SEC) regarding personnel changes.
2024-07-08 15:49 -
The Turbulent Times of Sirnaomics: Resignations, Cash Flow Concerns, and Operational Challenges
Sirnaomics, the "leader in China's nucleic acid drug industry" that dazzled the Hong Kong Stock Exchange with its listing in December 2021, has recent...
2024-07-08 15:47 -
Dupilumab Approved by EMA for COPD Treatment in Europe
Sanofi and Regeneron jointly announced that their co-developed drug, dupilumab (Dupixent), has successfully gone through the approval process of the E...
2024-07-08 15:46 -
Strategic Analysis of Bristol-Myers Squibb's Adjustment of MORAb-202 in the Global Landscape
From a strategic perspective, Bristol-Myers Squibb has been continuously adjusting the priority of its product portfolio in global strategic collabora...
2024-07-03 15:34 -
AstraZeneca Submits COVID-19 Preventive Drug Sipavibart for Accelerated Review in the EU
AstraZeneca stated in a Monday announcement that the European Union's drug regulatory agency has formally accepted the marketing authorization applica...
2024-07-01 17:26
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
